Market revenue in 2020 | USD 4,741.8 million |
Market revenue in 2028 | USD 16,679.0 million |
Growth rate | 17% (CAGR from 2020 to 2028) |
Largest segment | (crispr)/cas9 |
Fastest growing segment | (CRISPR)/Cas9 |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
Key market players worldwide | Thermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.
(crispr)/cas9 was the largest segment with a revenue share of 42.9% in 2020. Horizon Databook has segmented the Germany mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.
Germany accounted for a substantial revenue share in Europe’s mutation detection kits in genome editing market. Several initiatives are being undertaken in this country to expand the scope of genomic studies and gene editing tools drive the uptake of mutation detection kits in the country.
There is a major scope for research activities, coupled with rapid adoption of technologically advanced techniques, which can be attributed to the country’s major market share. Germany’s policies do not distinguish between gene-edited and genetically modified.
However, stringent regulatory guidelines are anticipated to affect commercialization of gene editing products and processes in the country. On the other hand, German biotechnology & pharmaceutical companies are actively engaged in the development of therapies by implementing various gene-editing technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany mutation detection kits in genome editing market , including forecasts for subscribers. This country databook contains high-level insights into Germany mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account